Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...

Roughly one in three preteens and teens ages 12 to 17 in the United States had prediabetes in 2023, according to new data ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...

Menopause can feel like one big balancing act. Between managing your hormone levels and symptoms like hot flashes, night ...

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor agonists offer neuroprotective and cerebrovascular benefits beyond what can ...

Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side effects.

Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping treatment.

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...